BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19294624)

  • 1. Radiological findings of early invasive pulmonary aspergillosis in immune-compromised patients.
    Brook O; Guralnik L; Hardak E; Oren I; Sprecher H; Zuckerman T; Engel A; Yigla M
    Hematol Oncol; 2009 Jun; 27(2):102-6. PubMed ID: 19294624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome.
    Hardak E; Yigla M; Avivi I; Fruchter O; Sprecher H; Oren I
    Bone Marrow Transplant; 2009 Nov; 44(9):595-9. PubMed ID: 19308034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
    Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
    Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?
    Horger M; Hebart H; Einsele H; Lengerke C; Claussen CD; Vonthein R; Pfannenberg C
    Eur J Radiol; 2005 Sep; 55(3):437-44. PubMed ID: 16129254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchogenic carcinoma and secondary aspergillosis--common yet unexplored: evaluation of the role of bronchoalveolar lavage-polymerase chain reaction and some nonvalidated serologic methods to establish early diagnosis.
    Shahid M; Malik A; Bhargava R
    Cancer; 2008 Aug; 113(3):547-58. PubMed ID: 18521930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
    Greene RE; Schlamm HT; Oestmann JW; Stark P; Durand C; Lortholary O; Wingard JR; Herbrecht R; Ribaud P; Patterson TF; Troke PF; Denning DW; Bennett JE; de Pauw BE; Rubin RH
    Clin Infect Dis; 2007 Feb; 44(3):373-9. PubMed ID: 17205443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patients.
    Jones ME; Fox AJ; Barnes AJ; Oppenheim BA; Balagopal P; Morgenstern GR; Scarffe JH
    J Clin Pathol; 1998 Sep; 51(9):652-6. PubMed ID: 9930067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients.
    Henzler C; Henzler T; Buchheidt D; Nance JW; Weis CA; Vogelmann R; Benck U; Viergutz T; Becher T; Boch T; Klein SA; Heidenreich D; Pilz L; Meyer M; Deckert PM; Hofmann WK; Schoenberg SO; Reinwald M
    Sci Rep; 2017 Jun; 7(1):4483. PubMed ID: 28667276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients.
    Park SY; Kim SH; Choi SH; Sung H; Kim MN; Woo JH; Kim YS; Park SK; Lee JH; Lee KH; Lee SG; Han DJ; Lee SO
    Transpl Infect Dis; 2010 Aug; 12(4):309-15. PubMed ID: 20202177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination between invasive pulmonary aspergillosis and pulmonary lymphoma using CT.
    Kawel N; Schorer GM; Desbiolles L; Seifert B; Marincek B; Boehm T
    Eur J Radiol; 2011 Mar; 77(3):417-25. PubMed ID: 19804951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of CT features of Aspergillus and bacterial pneumonia in severely neutropenic patients.
    Bruno C; Minniti S; Vassanelli A; Pozzi-Mucelli R
    J Thorac Imaging; 2007 May; 22(2):160-5. PubMed ID: 17527120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results.
    Buchheidt D; Baust C; Skladny H; Ritter J; Suedhoff T; Baldus M; Seifarth W; Leib-Moesch C; Hehlmann R
    Clin Infect Dis; 2001 Aug; 33(4):428-35. PubMed ID: 11462176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
    Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
    Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
    Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
    J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.